Providence Wealth Advisors, LLC Eli Lilly & CO Transaction History

Providence Wealth Advisors, LLC

$116 Million
Q1 2024

A detailed history of Providence Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 12,776 shares of LLY stock, worth $11.6 Million. This represents 8.58% of its overall portfolio holdings.

Number of Shares

12,776

Previous 12,931 1.2%

Holding current value

$11.6 Million

Previous $6.95 Million 43.11%

% of portfolio

8.58%

Previous 7.78%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $91,791 - $122,803	-155 Reduced 1.2%	12,776 $9.94 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $10,432 - $14,383	-24 Reduced 0.19%	12,931 $6.95 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $35,424 - $47,366	-101 Reduced 0.77%	12,955 $6.08 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $122,388 - $143,739	-394 Reduced 2.93%	13,056 $4.48 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $45,338 - $52,828	-141 Reduced 1.04%	13,450 $4.92 Million

Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $184,410 - $210,155	-622 Reduced 4.38%	13,591 $5.02 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $92,259 - $108,326	331 Added 2.38%	14,213 $4.66 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $7,040 - $8,749	30 Added 0.22%	13,882 $4.06 Million
Q4 2021 Jan 12, 2022	SELL	$224.85 - $279.04 $20,686 - $25,671	-92 Reduced 0.66%	13,852 $3.57 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $130,965 - $161,171	-591 Reduced 4.07%	13,944 $3.21 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $1,624 - $2,101	-9 Reduced 0.06%	14,535 $3.4 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $22,676 - $29,355	138 Added 0.96%	14,544 $2.72 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $2,217 - $2,934	-17 Reduced 0.12%	14,406 $2.41 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $24,126 - $27,906	-165 Reduced 1.13%	14,423 $2.14 Million
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $13,778 - $16,582	101 Added 0.7%	14,588 $2.4 Million
Q1 2020 May 05, 2020	BUY	$119.05 - $147.35 $2,738 - $3,389	23 Added 0.16%	14,487 $1.98 Million
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $110,341 - $136,667	-1,032 Reduced 6.66%	14,464 $1.9 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $4,271 - $4,646	-40 Reduced 0.26%	15,496 $1.73 Million
Q2 2019 Jul 22, 2019	SELL	$110.79 - $129.32 $38,554 - $45,003	-348 Reduced 2.19%	15,536 $1.75 Million
Q1 2019 Apr 18, 2019	BUY	$111.31 - $131.02 $21,816 - $25,679	196 Added 1.25%	15,884 $2.08 Million
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $14,508 - $16,253	-137 Reduced 0.87%	15,688 $1.79 Million
Q3 2018 Nov 01, 2018	SELL	$85.86 - $107.31 $9,187 - $11,482	-107 Reduced 0.67%	15,825 $1.7 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $12,414 - $14,248	-164 Reduced 1.02%	15,932 $1.36 Million
Q1 2018 Aug 14, 2018	BUY	$74.21 - $87.6 $1.19 Million - $1.41 Million	16,096 New	16,096 $1.22 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.

Account

Providence Wealth Advisors, LLC Eli Lilly & CO Transaction History